Dynavax (NASDAQ: DVAX) reported Q3 EPS of ($0.90), $0.15 worse than the analyst estimate of ($0.75). Revenue for the quarter came in at $162 thousand versus the consensus estimate of $2.44 million.

For earnings history and earnings-related data on Dynavax (DVAX) click here.